Abstract:Gasdermin D (GSDMD)-mediated pyroptotic cell death drives inflammatory cytokine release and downstream immune responses upon inflammasome activation, which play important roles in host defense and inflammatory disorders. Upon activation by proteases, the GSDMD N-terminal domain (NTD) undergoes oligomerization and membrane translocation in the presence of lipids to assemble pores. Despite intensive studies, the molecular events underlying the transition of GSDMD from an autoinhibited soluble form to an oligomeric pore form inserted into the membrane remain incompletely understood. Previous work characterized S -palmitoylation for gasdermins from bacteria, fungi, invertebrates, as well as mammalian gasdermin E (GSDME). Here, we report that a conserved residue Cys191 in human GSDMD was S -palmitoylated, which promoted GSDMD-mediated pyroptosis and cytokine release. Mutation of Cys191 or treatment with palmitoyltransferase inhibitors cyano-myracrylamide (CMA) or 2-bromopalmitate (2BP) suppressed GSDMD palmitoylation, its localization to the membrane and dampened pyroptosis or IL-1β secretion. Furthermore, Gsdmd -dependent inflammatory responses were alleviated by inhibition of palmitoylation in vivo. By contrast, coexpression of GSDMD with palmitoyltransferases enhanced pyroptotic cell death, while introduction of exogenous palmitoylation sequences fully restored pyroptotic activities to the C191A mutant, suggesting that palmitoylation-mediated membrane localization may be distinct from other molecular events such as GSDMD conformational change during pore assembly. Collectively, our study suggests that S -palmitoylation may be a shared regulatory mechanism for GSDMD and other gasdermins, which points to potential avenues for therapeutically targeting S -palmitoylation of gasdermins in inflammatory disorders.

Gasdermin D cysteine residues synergistically control its palmitoylation-mediated membrane targeting and assembly

Palmitoylation at a Conserved Cysteine Residue Facilitates Gasdermin D-mediated Pyroptosis and Cytokine Release

Gasdermin D palmitoylation: to cleave or not to cleave?

Palmitoylation of gasdermin D directs its membrane translocation and pore formation in pyroptosis

Mechanism of membrane pore formation by human gasdermin‐D

Crystal Structures of the Full-Length Murine and Human Gasdermin D Reveal Mechanisms of Autoinhibition, Lipid Binding, and Oligomerization.

Research Progress in Gasdermin Family Proteins and Their Association with Diseases

Gasdermin-A3 pore formation propagates along variable pathways

Structures of Gasdermin-D C-Terminal Domain Reveal Mechanisms of Autoinhibition

New insights into Gasdermin D pore formation

Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition.

Structure Insight of GSDMD Reveals the Basis of GSDMD Autoinhibition in Cell Pyroptosis.

Pore-forming activity and structural autoinhibition of the gasdermin family

Pyroptotic executioner pore-forming protein GSDMD forms oligomeric assembly and exhibits amyloid-like attributes that could contribute for its pore-forming function

Structure and assembly of a bacterial gasdermin pore

Recognition of Gasdermins by Proteases

Relaying gasdermin D to the membrane

Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation

Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway

Palmitoylation promotes pores

Molecular and Structural Aspects of Gasdermin Family Pores and Insights into Gasdermin-Elicited Programmed Cell Death